Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-08-16 00:00:00 ET · period of report 2021-08-12 · accession 0001209191-21-051618 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-16 | 2021-08-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | S - Sale+OE | $159.69 | -17.0K | 58.5K | -23% | -$2.71M |
| D | 2021-08-16 | 2021-08-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $1.16 | +17.0K | 60.6K | +39% | +$19.7K |
| D | 2021-08-16 | 2021-08-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $0.00 | -17.0K | 494.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-12 | S | D | 5,087 | $161.28 | 44,406 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $160.62 to $161.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-08-12 | S | D | 800 | $161.84 | 43,606 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $161.62 to $162.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-08-12 | S | D | 3,400 | $160.00 | 49,493 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $159.64 to $160.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-08-12 | S | D | 3,213 | $159.13 | 52,893 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $158.66 to $159.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-08-12 | S | D | 2,400 | $158.07 | 56,106 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $157.66 to $158.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-08-12 | S | D | 2,100 | $157.19 | 58,506 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $156.61 to $157.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-08-12 | M | A | 17,000 | $1.16 | 60,606 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2021-08-12 | M | D | 17,000 | $0.00 | 494,000 | D | $1.16 · — to 2027-02-03 | 17,000 Class A Common Stock | (F8) This option, originally for 800,000 shares, of which 306,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |